For more than 25 years, Ms. Kim has held leadership roles in biotechnology. She served as Strategic Advisor of NGM Biopharmaceuticals, Inc. from January, 2012 to November, 2014 and as their Chief Business Officer at NGM Biopharmaceuticals, Inc. from 2009 to 2012. Prior to NGM, she was the CEO and President of Kosan Biosciences, Inc. where she restructured and repositioned the company prior to its acquisition by Bristol-Myers Squibb in 2008. Additionally, Ms. Kim’s experience includes executive positions at Affymax, Onyx Pharmaceuticals, Protein Design Labs and Chiron Corporation where she served as head of global business development and marketing for therapeutics and vaccines businesses. Ms. Kim also recently served as Chief Program Officer for the Gordon and Betty Moore Foundation. She currently serves as a board member of Sunesis Pharmaceuticals, Forsight VISION 4 and Exicure Therapeutics. Ms. Kim received a B.S. in Chemical Engineering from Northwestern University and a M.B.A. from the University of Chicago.